カテゴリ： GlobalData, アメリカ, 企業調査

Quest Diagnostics Inc (DGX)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Quest Diagnostics Inc (DGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C9970
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：64
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology and diagnostic products. The company caters to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 17
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 18
Partnerships 19
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 19
Quintiles Forms Joint Venture with Quest Diagnostics 21
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 22
Licensing Agreements 23
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 23
Debt Offering 24
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 24
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 26
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 28
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 31
Asset Transactions 32
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 32
Acquisition 33
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 33
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 34
Spectra Labs To Acquire Shiel Medical Labs 35
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 36
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 37
Quest Diagnostics Inc – Key Competitors 38
Quest Diagnostics Inc – Key Employees 39
Quest Diagnostics Inc – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 43
Recent Developments 44
Financial Announcements 44
Oct 23, 2018: Quest Diagnostics reports third quarter 2018 financial results 44
Jul 24, 2018: Quest Diagnostics Reports Second Quarter 2018 Financial Results 45
Apr 19, 2018: Quest Diagnostics Reports First Quarter 2018 Financial Results 46
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 47
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 48
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 49
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 50
Corporate Communications 51
May 17, 2018: Quest Diagnostics adds Helen Torley to Board of Directors 51
Mar 06, 2017: Quest Diagnostics and American Diabetes Association to Help Identify People at Risk for Type 2 Diabetes 52
Legal and Regulatory 53
Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system 53
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 54
Government and Public Interest 55
Sep 06, 2018: Quest Diagnostics Health Trends Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent 55
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 57
Sep 06, 2017: Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis 58
Other Significant Developments 60
Jul 17, 2018: Quest Diagnostics: New Study Reveals Stalled Progress Toward Value-Based Care 60
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 62
Sep 22, 2017: Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Quest Diagnostics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 17
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 18
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 19
Quintiles Forms Joint Venture with Quest Diagnostics 21
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 22
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 23
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 24
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 26
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 28
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 31
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 32
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 33
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 34
Spectra Labs To Acquire Shiel Medical Labs 35
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 36
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 37
Quest Diagnostics Inc, Key Competitors 38
Quest Diagnostics Inc, Key Employees 39
Quest Diagnostics Inc, Subsidiaries 40
Quest Diagnostics Inc, Joint Venture 43

List of Figures
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Quest Diagnostics Inc (DGX)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • ITT Inc.：企業のM&A・事業提携・投資動向
    ITT Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITT Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • First Asset Investment Management Inc：企業の戦略的SWOT分析
    First Asset Investment Management Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • KEC International Ltd：企業の戦略・SWOT・財務情報
    KEC International Ltd - Strategy, SWOT and Corporate Finance Report Summary KEC International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Telecom Egypt Company：企業の戦略・SWOT・財務分析
    Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report Summary Telecom Egypt Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oleo e Gas Participacoes SA (OGXP3)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oleo e Gas Participacoes SA (OGX) is an oil and gas company that acquires and explores for oil and natural gas properties. The company operates a diversified portfolio of exploratory blocks located in offshore sedimentary basins in Brazil. It operates blocks located in onshore sedimentary ba …
  • Ackermans & Van Haaren NV：戦略・SWOT・企業財務分析
    Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report Summary Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Casio Computer Co Ltd (6952)：企業の財務・戦略的SWOT分析
    Casio Computer Co Ltd (6952) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cleco Corporate Holdings LLC：企業の戦略的SWOT分析
    Cleco Corporate Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Affimed GmbH (AFMD)：企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, is a clinical stage biopharmaceutical company which discovers and develops targeted cancer immunotherapies. The company’s pipeline product candidates include AFM11, AFM12, AFM13, AFM21 and AFM22, among othe …
  • True Corporation Public Company Limited：企業の戦略・SWOT・財務情報
    True Corporation Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary True Corporation Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Premier Farnell Ltd：企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Top Image Systems Ltd (TISA)：企業の戦略的SWOT分析
    Top Image Systems Ltd (TISA) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Compagnie de Saint-Gobain：企業のM&A・事業提携・投資動向
    Compagnie de Saint-Gobain - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compagnie de Saint-Gobain Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • CAB Incorporated：企業の戦略的SWOT分析
    CAB Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Enbridge Energy Partners, L.P.：企業の戦略・SWOT・財務情報
    Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Energy Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Intellect Design Arena Limited：戦略・SWOT・企業財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Centre for Drug Research and Development：製薬・医療：M&Aディール及び事業提携情報
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target valida …
  • Sberbank of Russia：企業のM&A・事業提携・投資動向
    Sberbank of Russia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sberbank of Russia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Core-Mark Holding Company, Inc. (CORE)：企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA：企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆